What does Dr. Peter Dekuyper - Urologie do?

Dr. Peter Dekuyper - Urologie is a specialist medical practice in Sint-Martens-Latem. Private Limited, started on 26 August 2004, 1 establishment.

What is the address of Dr. Peter Dekuyper - Urologie?

The registered office of Dr. Peter Dekuyper - Urologie is located at Kerkstraat 19, 9830 Sint-Martens-Latem.

Is Dr. Peter Dekuyper - Urologie still active?

Yes. According to the CBE (17 September 2026) Dr. Peter Dekuyper - Urologie is active, legal situation “Normale toestand”, started on 26 August 2004.

Is Dr. Peter Dekuyper - Urologie registered on Peppol?

Yes, Dr. Peter Dekuyper - Urologie is registered on the Peppol network with ID 0208:0866993423.

What is the enterprise number of Dr. Peter Dekuyper - Urologie?

The enterprise number of Dr. Peter Dekuyper - Urologie is BE0866993423.

When was Dr. Peter Dekuyper - Urologie founded?

Dr. Peter Dekuyper - Urologie was founded on 26 August 2004.

Who are the directors of Dr. Peter Dekuyper - Urologie?

According to the 2024 annual accounts, the directors of Dr. Peter Dekuyper - Urologie are: Peter DEKUYPER.

Is Dr. Peter Dekuyper - Urologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 August 2004; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr. Peter Dekuyper - Urologie make in 2024?

Dr. Peter Dekuyper - Urologie posted a profit after taxes of € 155,152 in financial year 2024.

What is the revenue of Dr. Peter Dekuyper - Urologie?

As a small company, Dr. Peter Dekuyper - Urologie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 254,457.

Dr. Peter Dekuyper - Urologie (Private Limited)

Dossier Dr. Peter Dekuyper - Urologie, printed on 17 September 2026 from databakkes.be/en/0866993423/dr-peter-dekuyper-urologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Dr. Peter Dekuyper - Urologie from Sint-Martens-Latem, company number BE0866993423, closed financial year 2024 with a result of € 155,152 after tax. For that financial year Dr. Peter Dekuyper - Urologie recorded a gross margin of € 254,457 and equity of € 972,057. Compared with financial year 2023, the result moved from € 111,751 to € 155,152. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 26, 2025.

What it is worth Growing

€ 972,057

▲ 7% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 155,152

▲ 39% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 156,900

▲ 89% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 88,798 paid out

57 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 15,114

▼ 8% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 25,183

Loans from banks and other lenders, long and short.

Taxes

€ 26,023

▲ 83% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 211,269 Gross margin 2021: € 211,269 First fiscal year in the series	€ 206,655 Gross margin 2022: € 206,655 ▼ 2% vs 2021 (€ 211,269) Unfavourable step	€ 195,648 Gross margin 2023: € 195,648 ▼ 5% vs 2022 (€ 206,655) Unfavourable step	€ 254,457 Gross margin 2024: € 254,457 ▲ 30% vs 2023 (€ 195,648) Favourable step	▲ 30%
Profit after taxes	€ 134,950 Profit after taxes 2021: € 134,950 First fiscal year in the series	€ 129,326 Profit after taxes 2022: € 129,326 ▼ 4% vs 2021 (€ 134,950) Unfavourable step	€ 111,751 Profit after taxes 2023: € 111,751 ▼ 14% vs 2022 (€ 129,326) Unfavourable step	€ 155,152 Profit after taxes 2024: € 155,152 ▲ 39% vs 2023 (€ 111,751) Favourable step	▲ 39%
Equity	€ 829,570 Equity 2021: € 829,570 First fiscal year in the series	€ 793,951 Equity 2022: € 793,951 ▼ 4% vs 2021 (€ 829,570) Unfavourable step	€ 905,702 Equity 2023: € 905,702 ▲ 14% vs 2022 (€ 793,951) Favourable step	€ 972,057 Equity 2024: € 972,057 ▲ 7% vs 2023 (€ 905,702) Favourable step	▲ 7%
Total debts	€ 38,189 Total debts 2021: € 38,189 First fiscal year in the series	€ 201,431 Total debts 2022: € 201,431 ▲ € 163,242 vs 2021 (€ 38,189) Unfavourable step	€ 39,372 Total debts 2023: € 39,372 ▼ 80% vs 2022 (€ 201,431) Favourable step	€ 51,205 Total debts 2024: € 51,205 ▲ 30% vs 2023 (€ 39,372) Unfavourable step	▲ 30%
Cash	€ 144,545 Cash 2021: € 144,545 First fiscal year in the series	€ 339,002 Cash 2022: € 339,002 ▲ 135% vs 2021 (€ 144,545) Favourable step	€ 82,825 Cash 2023: € 82,825 ▼ 76% vs 2022 (€ 339,002) Unfavourable step	€ 156,900 Cash 2024: € 156,900 ▲ 89% vs 2023 (€ 82,825) Favourable step	▲ 89%
Land & buildings	€ 133,852 Land & buildings 2021: € 133,852 First fiscal year in the series	€ 130,830 Land & buildings 2022: € 130,830 ▼ 2% vs 2021 (€ 133,852) Unchanged	€ 129,131 Land & buildings 2023: € 129,131 ▼ 1% vs 2022 (€ 130,830) Unchanged	€ 124,247 Land & buildings 2024: € 124,247 ▼ 4% vs 2023 (€ 129,131) Unchanged	▼ 4%
Retained profit	€ 810,970 Retained profit 2021: € 810,970 First fiscal year in the series	€ 775,351 Retained profit 2022: € 775,351 ▼ 4% vs 2021 (€ 810,970) Unfavourable step	€ 887,102 Retained profit 2023: € 887,102 ▲ 14% vs 2022 (€ 775,351) Favourable step	€ 953,457 Retained profit 2024: € 953,457 ▲ 7% vs 2023 (€ 887,102) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 164,946 Dividend 2022: € 164,946 Unchanged (€ 0) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 164,946) Unchanged	€ 88,798 Dividend 2024: € 88,798 Unchanged (€ 0) Unchanged
Bank debt	€ 10,055 Bank debt 2021: € 10,055 First fiscal year in the series	€ 25,049 Bank debt 2022: € 25,049 ▲ 149% vs 2021 (€ 10,055) Unfavourable step	€ 25,177 Bank debt 2023: € 25,177 ▲ 1% vs 2022 (€ 25,049) Unfavourable step	€ 25,183 Bank debt 2024: € 25,183 Unchanged (€ 25,177) Unfavourable step
Balance sheet total	€ 867,760 Balance sheet total 2021: € 867,760 First fiscal year in the series	€ 995,382 Balance sheet total 2022: € 995,382 ▲ 15% vs 2021 (€ 867,760) Unchanged	€ 945,074 Balance sheet total 2023: € 945,074 ▼ 5% vs 2022 (€ 995,382) Unchanged	€ 1,023,262 Balance sheet total 2024: € 1,023,262 ▲ 8% vs 2023 (€ 945,074) Unchanged	▲ 8%

Key figures of Dr. Peter Dekuyper - Urologie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr. Peter Dekuyper - Urologie?

What happened at Dr. Peter Dekuyper - Urologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 26, 2025 New annual accounts for financial year 2024: profit of € 155,152 (▲ 39% vs 2023). filed late Source: NBB ↗
Aug 26, 2004 New establishment in Sint-Martens-Latem. KBO
Aug 26, 2004 Start of the company according to the CBE. KBO

In short

From € 134,950 profit in 2021 to € 155,152 profit in 2024.

Paid € 244,576 in corporate taxes since 2021.

Best year ever: 2024, with € 155,152 profit.

Paid out € 253,743 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Peter Dekuyper - Urologie? We notify you, reason included.

Follow Dr. Peter Dekuyper - Urologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Peter DEKUYPER

Dr. Peter Dekuyper - Urologie

Behind Dr. Peter Dekuyper - Urologie is Peter DEKUYPER.

See the full network in the app

Directors

According to the 2024 annual accounts

Peter DEKUYPER

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kerkstraat 19

9830 Sint-Martens-Latem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0866.993.423
VAT number: BE 0866.993.423
Registered office: Kerkstraat 19, 9830 Sint-Martens-Latem
Names & denominations: Dr. Peter Dekuyper - Urologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 August 2004
Peppol: Active · Active since 4 Oct 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗